Vimarsana
Biggest News Aggregation in the World

Page 18 - Ouse Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ouse Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ouse Model Today - Breaking & Trending Today

Humanized mouse model for rare genetic disease developed for the first time - Vimarsana News

Humanized mouse model for rare genetic disease developed for the first time

Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time.

Ketogenic diet's surprising impact on opioid sensitivity and withdrawal - Vimarsana News

Ketogenic diet's surprising impact on opioid sensitivity and withdrawal

Research investigates the effects of a ketogenic diet (KD) on responses to oxycodone, a commonly prescribed opioid for pain management. The study found sex-biased effects of KD on oxycodone responses in mice, suggesting potential implications for clinical pain management and treatment of opioid use disorder.

Researchers evaluate the dual-therapeutic effect of gene therapy in mouse model of osteosarcoma - Vimarsana News

Researchers evaluate the dual-therapeutic effect of gene therapy in mouse model of osteosarcoma

Investigators at Brigham and Women’s Hospital and collaborating institutions evaluated the dual-therapeutic effect of gene therapy in a clinically relevant model for common form of bone cancer.

Study finds a pharmacological-based approach to revert immune escape of breast cancer cells - Vimarsana News

Study finds a pharmacological-based approach to revert immune escape of breast cancer cells

Freiburg researchers discover a mechanism by which cancer cells escape the immune system.

Neuropathic pain study uncovers pathophysiological mechanism and promising therapeutic target - Vimarsana News

Neuropathic pain study uncovers pathophysiological mechanism and promising therapeutic target

Neuropathic pain -; abnormal hypersensitivity to stimuli -; is associated with impaired quality of life and is often poorly managed. Estimates suggest that 3 percent to 17 percent of adults suffer from neuropathic pain, including a quarter of people with diabetes and a third of people with HIV.